IBM and Moderna released research on Thursday advancing the use of quantum computing in the development of mRNA medicines, a ...

International Business Machines said Thursday that it had joined forces with Moderna for a case study that evidenced quantum ...

Moderna's Spikevax vaccine has been fully approved for children with high-risk conditions, the first vaccine to do so.

Moderna stock has faced heavy pressure from negative headlines, regulatory setbacks and political uncertainty. See why I ...

Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 3.6% in the morning session after JPMorgan added the stock to its ...

The average short interest for the S&P 500 Health Care Index Sector (NYSEARCA:XLV) experienced an increase in June, moving ...

Moderna is expected to announce its second-quarter results in the upcoming month, and analysts expect a slight reduction in ...

Cambridge: Moderna has received approval from the U.S. Food and Drug Administration (FDA) for the supplemental Biologics ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

Jacobo Melcer, 85, of Bonita, admitted to paying kickbacks to multiple companies for the referral of Medicare beneficiaries and prescriptions for durable medical equipment, according to a July 2 ...

The FDA published a database of letters sent to drugmakers during the review process of medications that provide information on the agency's initial feedback or requirements for more data. These ...

Morgan Stanley analyst Terence Flynn maintained a Hold rating on Moderna today and set a price target of $31.00. The company’s shares opened today at $33.30. Elevate Your Invest ...